ICD-10-CM Diagnosis Code Quick Reference Guide
This list includes ICD-10 codes that may be relevant for patients with agitation associated with dementia due to Alzheimer’s disease. Read More
- About
- PsychU For You
- Topics
- Events
- Content
Agitation
Addressing Caregiver Burden & Identifying Agitation in Alzheimer’s Dementia
Come and join us for this webinar, as our speaker and moderator highlight the impact of caregiver burden, discuss challenges in recognizing agitation in Alzheimer’s dementia, and share tools that… Read MoreUnmet Needs In Agitation Associated With Alzheimer’s Dementia (AAD)
This evidence-based review highlights important aspects of agitation associated with Alzheimer’s Dementia (AAD) for better understanding of the prevalence and challenges in diagnosis and explore the potential pathobiological correlations in… Read MoreThe Agitation in Alzheimer’s Screener For Caregivers (AASC™) – A New Tool To Disease Recognition
This presentation focuses on defining agitation in Alzheimer’s dementia including symptom presentation, prevalence and burden on patients and caregivers. Read MoreVirtual Event – Pathophysiology Of Agitation Associated With Alzheimer’s Dementia (AD) – The Potential Role Of The Norepinephrine, Serotonin & Dopamine (NSD) Neurotransmitter Systems
Becky Wong, PharmD, MBA is an employee of Otsuka Pharmaceutical Development & Commercialization, Inc. (OPDC) E. Jeffrey Greenberg, MD is a paid speaker on behalf of Otsuka Pharmaceutical Development &… Read MoreVirtual Event – The Agitation in Alzheimer’s Screener For Caregivers (AASC™) – A New Tool To Disease Recognition
Michelle Lavagnino, DrPH(c) and Becky Wong, PharmD, MBA are employees of Otsuka Pharmaceutical Development & Commercialization, Inc. (OPDC) Read MoreUnmet Needs In Agitation Associated With Alzheimer’s Dementia (AAD)
Amaka Onyereri, PharmD, BCPS (OPDC) is an employee of Otsuka Pharmaceutical Development & Commercialization, Inc. (OPDC) PSYCHU PROGRAM ATTENDANCE ELIGIBILITY REQUIREMENTS PsychU is supported by Otsuka Pharmaceutical Developmental & Commercialization… Read MoreThe Agitation in Alzheimer’s Screener for Caregivers (AASC™): How Caregivers Can Use This New Screener to Recognize the Breadth of Agitation Symptoms & Facilitate Conversations With Healthcare Professionals
As a follow-up to the previous webinar, “An Introduction to the AASC™,” this webinar will re-ground on the current landscape of Alzheimer’s dementia (AD) and the negative impact agitation in… Read MoreUnmet Needs In Agitation Associated With Alzheimer’s Dementia (AAD)
Linzy Hendrickson, PhD (OPDC) is an employee of Otsuka Pharmaceutical Development & Commercialization, Inc. (OPDC) PSYCHU PROGRAM ATTENDANCE ELIGIBILITY REQUIREMENTS PsychU is supported by Otsuka Pharmaceutical Developmental & Commercialization Inc.,… Read MoreClinical Perspectives on the Impact of Agitation in Alzheimer’s Dementia Among the Hispanic Community
Freddi Segal-Gidan, PA PhD is a volunteer and has declined payment for this activity. Daniel Jimenez, PhD is a paid consultant of Otsuka Pharmaceutical Development & Commercialization, Inc. John Awad,… Read More - PsychU For You
